Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niti Goel

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Rheumatology|February 3, 2017
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016Ana-Maria Orbai, Maarten de Wit, Philip J Mease, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|November 2, 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working GroupDorthe B Berthelsen, Lee S Simon, John P A Ioannidis, et al.
The Journal of Rheumatology|February 17, 2017
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest GroupJennifer Petkovic, Jennifer L Barton, Caroline Flurey, et al.
Nature Reviews. Rheumatology|June 27, 2022
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021Laura C Coates, Enrique R Soriano, Nadia Corp, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.
BMJ Open|December 15, 2025
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trialsMaja Skov Kragsnaes, Benoit Thomas P Gilbert, Bjørk Khaliqi Sofíudóttir, et al.
The Journal of Rheumatology|August 1, 2023
Proceedings of the GRAPPA 2022 Executive RetreatBeverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|February 3, 2017
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016Ana-Maria Orbai, Maarten de Wit, Philip J Mease, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|November 2, 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working GroupDorthe B Berthelsen, Lee S Simon, John P A Ioannidis, et al.
The Journal of Rheumatology|February 17, 2017
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest GroupJennifer Petkovic, Jennifer L Barton, Caroline Flurey, et al.
Nature Reviews. Rheumatology|June 27, 2022
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021Laura C Coates, Enrique R Soriano, Nadia Corp, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.
BMJ Open|December 15, 2025
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trialsMaja Skov Kragsnaes, Benoit Thomas P Gilbert, Bjørk Khaliqi Sofíudóttir, et al.
The Journal of Rheumatology|August 1, 2023
Proceedings of the GRAPPA 2022 Executive RetreatBeverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Pageof 10